 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123456789101112» |
- | QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
Trial completion: OLiVIA: Effects of QVAR in Smokers With Asthma (clinicaltrials.gov) - Aug 26, 2016
P4, N=40, Completed, Sponsor: University Medical Center Groningen
Recruiting --> Completed
- |||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment open, Trial initiation date: A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils (clinicaltrials.gov) - Aug 2, 2016
P2/3, N=130, Recruiting, Sponsor: Mundipharma Research Limited
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jul 2016
- |||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment open, Heterogeneity: A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar (clinicaltrials.gov) - Aug 2, 2016
P3, N=120, Recruiting, Sponsor: Mundipharma Research Limited
Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jul 2016 Not yet recruiting --> Recruiting
- |||| Onbrez (indacaterol) / Novartis
Trial completion, Trial primary completion date: COMBINE: Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD (clinicaltrials.gov) - Jul 16, 2016
P4, N=228, Completed, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Completed | Trial primary completion date: Jun 2015 --> Jan 2016
- fluticasone / Generic mfg.
Trial completion, Enrollment change, Surgery: Comparison of Nasal Steroids After FESS in CRSwNP (clinicaltrials.gov) - Jul 13, 2016
P=N/A, N=32, Completed, Sponsor: Yale University
Not yet recruiting --> Completed | Trial primary completion date: Jun 2015 --> Jan 2016 Recruiting --> Completed | N=60 --> 32
- ||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
New trial, Adherence: Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice. (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=250, Not yet recruiting, Sponsor: Mundipharma Pharmaceuticals B.V.
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
New P3 trial, Heterogeneity: A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar (clinicaltrials.gov) - Apr 28, 2016
P3, N=120, Not yet recruiting, Sponsor: Mundipharma Research Limited
- | fluticasone / Generic mfg.
Enrollment closed: STICS: Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (clinicaltrials.gov) - Apr 14, 2016
P3, N=250, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | N=60 --> 32 Recruiting --> Active, not recruiting
- fluticasone / Generic mfg.
Enrollment open, Trial initiation date, Heterogeneity: EXPAND: Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma (clinicaltrials.gov) - Mar 16, 2016
P4, N=30, Recruiting, Sponsor: University of Virginia
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Nov 2015 --> Mar 2016
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
New P2/3 trial: A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils (clinicaltrials.gov) - Feb 29, 2016
P2/3, N=130, Not yet recruiting, Sponsor: Mundipharma Research Limited
- fluticasone / Generic mfg.
Trial termination: InFLOWt: Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=58, Terminated, Sponsor: VA Office of Research and Development
Not yet recruiting --> Recruiting | Initiation date: Nov 2015 --> Mar 2016 Recruiting --> Terminated; Low subject accrual
- fluticasone / Generic mfg.
New trial: Changes in the Lung Clearance Index in Pediatric Patients With Asthma (clinicaltrials.gov) - Feb 10, 2016
P=N/A, N=105, Not yet recruiting, Sponsor: Hospital Infantil de Mexico Federico Gomez
- ||||||| Xhance (fluticasone propionate intranasal spray) / OptiNose
Trial completion: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device (clinicaltrials.gov) - Feb 4, 2016
P3, N=223, Completed, Sponsor: Optinose US Inc.
Recruiting --> Terminated; Low subject accrual Active, not recruiting --> Completed
- montelukast / Generic mfg., fluticasone / Generic mfg.
Trial primary completion date: Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone (clinicaltrials.gov) - Jan 30, 2016
P3, N=100, Active, not recruiting, Sponsor: Medical College of Wisconsin
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Aug 2016
- Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
New P3 trial: Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis (clinicaltrials.gov) - Jan 28, 2016
P3, N=32, Not yet recruiting, Sponsor: Tehran University of Medical Sciences
- prednisolone / Generic mfg., fluticasone / Generic mfg.
Trial completion, Enrollment change: Management of Recurrent Croup (clinicaltrials.gov) - Nov 10, 2015
P3, N=10, Completed, Sponsor: University of Michigan
Trial primary completion date: Dec 2015 --> Aug 2016 Recruiting --> Completed | N=100 --> 10
- fluticasone / Generic mfg.
New P4 trial, Heterogeneity: EXPAND: Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma (clinicaltrials.gov) - Oct 22, 2015
P4, N=30, Not yet recruiting, Sponsor: University of Virginia
- ||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Trial completion, Trial primary completion date: A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers (clinicaltrials.gov) - Sep 28, 2015
P1, N=125, Completed, Sponsor: Mundipharma Research Limited
Recruiting --> Completed | N=100 --> 10 Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Oct 2014
- montelukast / Generic mfg., fluticasone / Generic mfg.
Trial primary completion date: Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone (clinicaltrials.gov) - Aug 13, 2015
P3, N=100, Active, not recruiting, Sponsor: Medical College of Wisconsin
Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Oct 2014 Trial primary completion date: Dec 2014 --> Dec 2015
- ||||| montelukast / Generic mfg., fluticasone / Generic mfg.
Trial initiation date: A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910) (clinicaltrials.gov) - Jun 23, 2015
P3, N=994, Completed, Sponsor: Merck Sharp & Dohme Corp.
Trial primary completion date: Dec 2014 --> Dec 2015 Initiation date: Jul 2001 --> Oct 2001
- ||||||| formoterol/fluticasone / Generic mfg., fluticasone / Generic mfg.
Trial completion, Head-to-Head: A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients (clinicaltrials.gov) - Jun 18, 2015
P3, N=222, Completed, Sponsor: Eurofarma Laboratorios S.A.
Initiation date: Jul 2001 --> Oct 2001 Active, not recruiting --> Completed
- fluticasone / Generic mfg.
Trial primary completion date: STICS: Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (clinicaltrials.gov) - Apr 14, 2015
P3, N=250, Recruiting, Sponsor: Milton S. Hershey Medical Center
Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> May 2017
- ||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
New P1 trial: A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers (clinicaltrials.gov) - Mar 31, 2015
P1, N=125, Recruiting, Sponsor: Mundipharma Research Limited
- ||| Veramyst (fluticasone furoate nasal spray) / GSK
Trial completion: Special Drug Use Investigation for ALLERMIST (Long Term) (clinicaltrials.gov) - Mar 27, 2015
P=N/A, N=500, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Aug 2016 --> May 2017 Active, not recruiting --> Completed
- | Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Trial completion: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. (clinicaltrials.gov) - Jan 28, 2015
P2, N=48, Completed, Sponsor: Mundipharma Research Limited
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| fluticasone / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date, Surgery: Comparison of Nasal Steroids After FESS in CRSwNP (clinicaltrials.gov) - Jan 26, 2015
P=N/A, N=60, Recruiting, Sponsor: Yale University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Jul 2014 --> Jan 2015 | Trial primary completion date: Jan 2015 --> Jul 2015
- ||||| Xhance (fluticasone propionate intranasal spray) / OptiNose
Enrollment closed, Trial primary completion date: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device (clinicaltrials.gov) - Jan 26, 2015
P3, N=200, Active, not recruiting, Sponsor: Optinose US Inc.
Not yet recruiting --> Recruiting | Initiation date: Jul 2014 --> Jan 2015 | Trial primary completion date: Jan 2015 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2015
- fluticasone / Generic mfg.
Enrollment change, Trial termination: Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children (clinicaltrials.gov) - Jan 9, 2015
P3, N=54, Terminated, Sponsor: Elena Rubio Gomis
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2015 N=100 --> 54 | Recruiting --> Terminated; Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm).
- fluticasone / Generic mfg.
Enrollment change: Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=32, Completed, Sponsor: University of Miami
N=100 --> 54 | Recruiting --> Terminated; Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm). N=50 --> 32
- fluticasone / Generic mfg.
Trial primary completion date: Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma (clinicaltrials.gov) - Nov 25, 2014
P=N/A, N=143, Recruiting, Sponsor: Rhode Island Hospital
N=50 --> 32 Trial primary completion date: Jul 2014 --> Jul 2016
- ||| fluticasone / Generic mfg.
Enrollment open: Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=122, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Jul 2014 --> Jul 2016 Not yet recruiting --> Recruiting
- | fluticasone / Generic mfg.
Enrollment open: AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) (clinicaltrials.gov) - Nov 11, 2014
P4, N=45, Recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | fluticasone / Generic mfg.
Enrollment open: SPARK: Steroids for Pediatric Apnea Research in Kids (clinicaltrials.gov) - Sep 30, 2014
P3, N=318, Recruiting, Sponsor: Children's Hospital of Philadelphia
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- fluticasone / Generic mfg.
New P4 trial: AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) (clinicaltrials.gov) - Sep 12, 2014
P4, N=45, Not yet recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
- | Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment closed: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. (clinicaltrials.gov) - Aug 7, 2014
P2, N=48, Active, not recruiting, Sponsor: Mundipharma Research Limited
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- fluticasone / Generic mfg.
New P4 trial: Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD (clinicaltrials.gov) - Aug 6, 2014
P4, N=23, Completed, Sponsor: Hospital Son Llatzer
- | fluticasone / Generic mfg.
Trial completion: A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations (clinicaltrials.gov) - Aug 3, 2014
P1, N=15, Completed, Sponsor: University of Chicago
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||||| beclometasone/formoterol / Generic mfg., fluticasone / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion, Enrollment change: A Study in Patients With Asthma (clinicaltrials.gov) - Jul 24, 2014
P3, N=108, Completed, Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting --> Completed Active, not recruiting --> Completed | N=90 --> 108
- fluticasone / Generic mfg.
Surgery: Comparison of Nasal Steroids After FESS in CRSwNP (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=60, Not yet recruiting, Sponsor: Yale University
- fluticasone / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=84, Completed, Sponsor: Milton S. Hershey Medical Center
Active, not recruiting --> Completed | N=90 --> 108 Recruiting --> Completed | N=63 --> 84 | Trial primary completion date: Jan 2014 --> Jul 2014
- | fluticasone / Generic mfg.
Enrollment open: STICS: Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (clinicaltrials.gov) - Jul 12, 2014
P3, N=250, Recruiting, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | N=63 --> 84 | Trial primary completion date: Jan 2014 --> Jul 2014 Not yet recruiting --> Recruiting
- || Veramyst (fluticasone furoate nasal spray) / GSK
Trial primary completion date: Special Drug Use Investigation for ALLERMIST (Long Term) (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=500, Active, not recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Trial primary completion date: Nov 2013 --> Aug 2014
- || fluticasone / Generic mfg.
New P3 trial: SPARK: Steroids for Pediatric Apnea Research in Kids (clinicaltrials.gov) - Jul 4, 2014
P3, N=318, Not yet recruiting, Sponsor: Children's Hospital of Philadelphia
- montelukast / Generic mfg., fluticasone / Generic mfg.
Enrollment change: A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) (clinicaltrials.gov) - Jul 1, 2014
P3, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
Trial primary completion date: Nov 2013 --> Aug 2014 N=2100 --> 0
- | QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
Enrollment open: OLiVIA: Effects of QVAR in Smokers With Asthma (clinicaltrials.gov) - Jun 18, 2014
P4, N=40, Recruiting, Sponsor: University Medical Centre Groningen
N=2100 --> 0 Not yet recruiting --> Recruiting
- ||| Onbrez (indacaterol) / Novartis
Trial initiation date: COMBINE: Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD (clinicaltrials.gov) - May 20, 2014
P4, N=280, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting Initiation date: Feb 2014 --> Jun 2014
- Xolair (omalizumab) / Roche, Novartis
Trial completion: PROSE: Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (clinicaltrials.gov) - Apr 30, 2014
P4, N=494, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Initiation date: Feb 2014 --> Jun 2014 Active, not recruiting --> Completed
- | Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment open: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. (clinicaltrials.gov) - Mar 2, 2014
P2, N=48, Recruiting, Sponsor: Mundipharma Research Limited
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | fluticasone / Generic mfg., esomeprazole / Generic mfg.
Trial completion: Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis (clinicaltrials.gov) - Feb 22, 2014
P2, N=30, Completed, Sponsor: University of Utah
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||| pimecrolimus topical / Generic mfg., fluticasone propionate / Generic mfg.
Trial completion, Combination therapy: Combination Therapy for Atopic Dermatitis (clinicaltrials.gov) - Feb 22, 2014
P4, N=90, Completed, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Completed No longer recruiting --> Completed